The Asia-Pacific contract research organization market was valued at US$ 8,112.00 million in 2020, and it is projected to reach US$ 18,399.87 million by 2028; it is expected to grow at a CAGR of 11.2% during 2021–2028. The market growth is attributed to the key driving factors such as the increasing R&D expenditures and outsourcing activities and rising number of clinical trials in Asia-Pacific. However, the availability of skilled professionals hinders the growth of the market.
A contract research organization (CRO) provides support services to the pharmaceutical, biotechnology, and medical device companies throughout the development of the product. Pharmaceutical & biotechnology companies and the medical device industry require various testing services such as preclinical services, clinical research services, analytical testing services, bioanalytical testing services, and regulatory services. CROs are specifically designed to perform these testing services to reduce the in-house cost and time of the companies required to conduct the extensive range of testing services to comply with the national and international regulatory standards.
Based on type, the Asia-Pacific contract research organization market is segmented into early phase services, clinical research services, laboratory services, and post-approval services. The clinical research services segment held the largest market share in 2020, and the same segment is expected to register the highest CAGR during the forecast period.
By end user, the Asia-Pacific contract research organization market is segmented into pharmaceutical & biotechnology companies and medical devices companies. The pharmaceutical & biotechnology companies segment held larger share of the market in 2020 and the same segment is expected to register higher CAGR in the market during 2021–2028.
Food and Drug Administration (FDA), India Brand Equity Foundation (IBEF), and Pharmaceutical and Medical Devices Agency (PMDA) are among the secondary sources referred to while preparing the report on the Asia-Pacific contract research organization market.
Reasons to Buy
A contract research organization (CRO) provides support services to the pharmaceutical, biotechnology, and medical device companies throughout the development of the product. Pharmaceutical & biotechnology companies and the medical device industry require various testing services such as preclinical services, clinical research services, analytical testing services, bioanalytical testing services, and regulatory services. CROs are specifically designed to perform these testing services to reduce the in-house cost and time of the companies required to conduct the extensive range of testing services to comply with the national and international regulatory standards.
Based on type, the Asia-Pacific contract research organization market is segmented into early phase services, clinical research services, laboratory services, and post-approval services. The clinical research services segment held the largest market share in 2020, and the same segment is expected to register the highest CAGR during the forecast period.
By end user, the Asia-Pacific contract research organization market is segmented into pharmaceutical & biotechnology companies and medical devices companies. The pharmaceutical & biotechnology companies segment held larger share of the market in 2020 and the same segment is expected to register higher CAGR in the market during 2021–2028.
Food and Drug Administration (FDA), India Brand Equity Foundation (IBEF), and Pharmaceutical and Medical Devices Agency (PMDA) are among the secondary sources referred to while preparing the report on the Asia-Pacific contract research organization market.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific contract research organization market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific contract research organization market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Table of Contents
1. Introduction
3. Research Methodology
4. Asia-Pacific Contract Research Organization Market- Market Landscape
5. Contract Research Organization Market - Key Market Dynamics
6. Contract Research Organization Market- Asia-Pacific Analysis
7. Contract Research Organization (CRO) Market Analysis - By Type
8. Contract Research Organization (CRO) Market Analysis - By End User
9. Contract Research Organization Market Analysis and Forecasts To 2028 - Geographical Analysis
10. Impact of COVID-19 Pandemic on Asia-Pacific Contract Research Organization Market
11. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- IQVIA Inc.
- Parexel International Corporation
- Charles River Laboratories, Inc.
- ACM Global Laboratories
- Merck KGaA (Bio Reliance Corporation)
- Celerion
- Clinitude
- Laboratory Corporation of America Holdings (Covance Inc.)
- Novotech
- Icon PLC
Table Information
Report Attribute | Details |
---|---|
Published | April 2021 |
Forecast Period | 2020 - 2028 |
Estimated Market Value ( USD | $ 8112 Million |
Forecasted Market Value ( USD | $ 18399.87 Million |
Compound Annual Growth Rate | 11.2% |
Regions Covered | Asia Pacific |